1. What Is the Digital Biomarker Sleep Market?
The Digital Biomarker Sleep Market comprises wearable, contactless, and smartphone technologies that passively monitor sleep stages and quality as digital biomarkers. It is a digital-health software and sensor market measuring sleep remotely outside polysomnography laboratory settings. The market includes wearable actigraphy and PPG, contactless radar, bed-sensor, and smartphone sleep-biomarker monitoring modalities. Multi-sensor wearable rings and watches measuring sleep staging with PSG-correlated accuracy represent the current technology frontier. Scope spans sleep-stage, sleep-quality and efficiency, sleep-apnea and breathing, and circadian-rhythm biomarker measurement applications. These biomarkers support remote insomnia and sleep-apnea monitoring, psychiatric-condition sleep tracking, and clinical-trial sleep-endpoint measurement. End users include pharmaceutical and biotech companies, sleep-medicine and psychiatry programs, digital-therapeutics companies, and consumer-health users. Digital-biomarker companies and wearable-device manufacturers together develop and validate remote sleep-sensing algorithms against polysomnographic reference. The scope excludes clinical polysomnography conducted in accredited sleep-laboratory settings and general consumer fitness-tracker step-count devices.
2. Digital Biomarker Sleep Market Size & Forecast
3. Emerging Technologies
- AI-Powered Digital Biomarker Sleep Frameworks analyze real-time operational data streams to predict workflow demand accurately. Enterprise teams deploy automated machine learning models to accelerate processing throughput by forty percent.
- Cloud-Native Digital Biomarker Sleep Architecture enables scalable multi-tenant asset management across distributed cloud nodes. System administrators utilize containerized microservices to lower infrastructure latency and maintain system uptime.
- Zero-Trust Digital Biomarker Sleep Protocols enforce continuous identity verification and cryptographic encryption across all user access points. Security teams integrate automated policy enforcement software to mitigate cyber threats across enterprise networks.
- Real-Time Digital Biomarker Sleep SDKs process high-volume transactional metrics to generate actionable business intelligence dashboards. Executive decision-makers utilize predictive telemetry feeds to optimize resource allocation and strategic planning.
Such innovations are driving change across adjacent industries too. Discover more in our Digital Biomarker Anxiety Market.
4. Key Market Opportunity
A major opportunity in the Digital Biomarker Sleep Market is contactless radar-based sleep monitoring eliminating the wearable device compliance problem that patients who forget or refuse to wear a tracker create for continuous programs. Wearable sleep trackers depend on consistent nightly compliance, and patients who forget to wear the device or find it uncomfortable create monitoring gaps that undermine the continuous longitudinal data sleep programs are trying to collect. Contactless radar monitoring platforms from ResMed and ballistocardiography sensor developers are detecting sleep stage and breathing pattern data from a bedside device requiring no physical contact, eliminating wearable compliance dependency. Sleep programs adopting contactless monitoring will eliminate the wearable compliance gaps that undermine continuous tracking, and extend monitoring to patients who refuse or forget to wear a device consistently.
5. Top Companies in the Digital Biomarker Sleep Market
The following organisations hold leading positions in the Digital Biomarker Sleep Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Oura Health
- SleepScore Labs
- Big Health (Sleepio)
- ResMed
- Whoop
- Fitbit (Fitbit Premium)
- Garmin (Garmin Sleep)
- Apple (Apple Watch Sleep)
- Google (Google Fit Sleep)
- Amazon (Halo Sleep)
- Dreem
- Neurable (BrainBit)
- Philips (Philips SleepMapper)
- Oura Health
- Biostrap
6. Market Segmentation
The Digital Biomarker Sleep Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Measurement Method | Wearable Sleep Biomarkers Actigraphy Sleep Biomarkers PPG-Based Sleep Biomarkers Contactless and Radar Sleep Biomarkers Bed-Sensor Sleep Biomarkers Smartphone Sleep Biomarkers |
| By Sleep Metric | Sleep-Stage Biomarkers Standard Sleep-Stage Biomarkers Premium Sleep-Stage Biomarkers Sleep-Quality and Efficiency Biomarkers Sleep-Apnea and Breathing Biomarkers Circadian-Rhythm Biomarkers |
| By Application | Sleep-Disorder Screening Commercial Sleep-Disorder Screening Industrial Sleep-Disorder Screening Sleep Monitoring and Tracking Treatment-Response Sleep Monitoring |
| By Care Context | Consumer Sleep Biomarkers Primary Consumer Sleep Biomarkers Secondary Consumer Sleep Biomarkers Clinical Sleep Biomarkers Clinical-Trial Sleep Biomarkers |
| By End User | Consumers and Wellness Premium Consumers and Wellness Mainstream Consumers and Wellness Sleep Clinics and Providers Pharmaceutical and Trials Digital-Health Companies |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Digital Biomarker Sleep Market trajectory over the forecast period:
Sleep-Health Monitoring Demand Is Driving Sleep Digital Biomarkers.Tracking sleep remotely for health and disease monitoring is driving sleep digital biomarker adoption in research and consumer health. Withings and Oura expanded sleep tracking in 2024, and Koneksa advanced validated sleep digital biomarkers for clinical drug development applications.
Wearable and Contactless Sleep Sensing Are Advancing Sleep Biomarkers.Wearable and contactless radar sleep sensing are advancing objective remote sleep-stage and quality measurement. Oura expanded wearable sleep staging in 2024, and Withings advanced contactless sleep sensing improving remote sleep digital biomarker measurement.
Sleep Biomarkers Are Gaining Clinical and Trial Adoption.Validated sleep biomarkers are gaining adoption as clinical and trial endpoints, driving pharmaceutical and research use. Koneksa and Clario advanced validated sleep digital biomarkers in 2024 for clinical trial sleep and circadian endpoint measurement.
For related market intelligence, see the Digital Biomarker Depression Market.
8. Segmental Analysis
By measurement method, the wearable sleep biomarkers segment dominated the Digital Biomarker Sleep Market in 2025, driven by high clinical adoption rates, established reimbursement frameworks, and major cardiology guidelines endorsement. Electrophysiologists and heart failure cardiologists continue expanding device implantation volumes as clinical practice guidelines specify therapy in eligible patient populations meeting prevention criteria. The actigraphy sleep biomarkers segment is the fastest-growing measurement method category, driven by expanding clinical indications in heart failure management and growing adoption of non-invasive monitoring technologies. Clinical specialists and hospital care teams are increasing patient referral rates as prospective clinical trials demonstrate therapeutic benefit across broader patient demographics.
By sleep metric, the sleep-stage biomarkers segment dominated the Digital Biomarker Sleep Market in 2025, driven by high clinical adoption rates, established reimbursement frameworks, and major cardiology guidelines endorsement. Electrophysiologists and heart failure cardiologists continue expanding device implantation volumes as clinical practice guidelines specify therapy in eligible patient populations meeting prevention criteria. The tertiary care hospitals segment is the fastest-growing sleep metric category, driven by expanding clinical indications in heart failure management and growing adoption of non-invasive monitoring technologies. Clinical specialists and hospital care teams are increasing patient referral rates as prospective clinical trials demonstrate therapeutic benefit across broader patient demographics.
9. Regional Analysis
Regional demand patterns across the Digital Biomarker Sleep Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Digital Biomarker Sleep Market in 2025, with a market share of 40.80% of overall global revenue. Early commercial adoption of advanced technological platforms, mature enterprise infrastructure, and high regional technology spending drive market leadership. High consumer per-capita income and extensive presence of major industry solution providers reinforce ongoing dominance across the territory. The region is expected to retain its top revenue-contributing position through 2034 propelled by ongoing corporate infrastructure investments.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 25.10% during the forecast period from 2025 to 2034. Swift expansion of high-speed 5G mobile communications and surging digital infrastructure investments across China, India, and Southeast Asia fuel market expansion. Expanding urban middle-class populations and rising commercial technology adoption across developing Asian economies enable millions of new users. Regional service providers are scaling infrastructure deployments to capture expanding commercial demand across emerging Asian markets.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Digital Biomarker Sleep Market was valued at USD 650.51 Mn in 2025 and is projected to reach USD 4,040.88 Mn by 2034, growing at a CAGR of 22.50% over the 2026–2034 forecast period.
The Digital Biomarker Sleep Market is projected to grow at a CAGR of 22.50% from 2026 to 2034.
North America dominated the Digital Biomarker Sleep Market in 2025, with a market share of 40.80% of overall global revenue.
The leading companies in the Digital Biomarker Sleep Market include Oura Health, SleepScore Labs, Big Health (Sleepio), ResMed, Whoop, Fitbit (Fitbit Premium), Garmin (Garmin Sleep), Apple (Apple Watch Sleep), Google (Google Fit Sleep), Amazon (Halo Sleep), Dreem, Neurable (BrainBit), Philips (Philips SleepMapper), Oura Health, Biostrap.
Sleep-health monitoring demand is driving sleep digital biomarkers.
By measurement method, the wearable sleep biomarkers segment dominated the Digital Biomarker Sleep Market in 2025, driven by high clinical adoption rates, established reimbursement frameworks, and major cardiology guidelines endorsement.
How to Order
Choose Your Package
Who competes in this market, how large each player is, and where they sit against each other.
- Business overview, HQ, headcount & ownership
- Product and brand portfolio mapped per company
- Recent developments: launches, M&A, partnerships, capacity
- SWOT and strategic posture for each player
- 2025 market share split by company, plus “others”
- Company revenue mapping in USD Mn
- Competitive landscape matrix & quadrant positioning
- Concentration read: top-5 share and fragmentation
The forecast model itself. Every table from the study as clean, formula-ready Excel across 5 segmentation axes. Choose how much geography you need.
- One country, broken out across 5 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 5 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack (Package 2.3)
- Complete research methodology, assumptions & appendix
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.